FDA Wants Compounding Authority Clarified, Congress Not So Sure It’s Necessary

Commissioner Hamburg asks for more power over non-traditional compounding to better regulate companies like the New England Compounding Center, but several House members say it looks like the agency already has the authority it needs.

FDA is arguing for more authority over some types of compounding to prevent future problems like the deadly meningitis outbreak at the New England Compounding Center, but many House members are not convinced it is necessary.

Several Republican members of the House Energy and Commerce Committee Oversight and Investigations Committee suggested during a Nov. 14 hearing...